Abstract
Nipradilol (3,4-dihydro-8-(2-hydroxy-3-isopropylamino)propoxy-3-nitroxy-2H-1-benzopyran) is used clinically as an anti-glaucoma ophthalmic solution in Japan, and was recently reported to suppress N-methyl-d-aspartate-induced retinal damage in rats. Here we investigated cytotoxic and cytoprotective actions of nipradilol on primary cultures of rat cortical neurons. Treatment of cortical cultures with a high concentration (500 microM) of nipradilol significantly reduced cell viability, increased lactate dehydrogenase (LDH) release and nitrite concentration in culture medium, whereas desnitro-nipradilol (3,4-dihydro-8-(2-hydroxy-3-isopropylamino)propoxy-3-hydroxy-2H-1-benzopyran) had no significant effects. Nipradilol-induced neuronal damage was inhibited by S-hexylglutathione, a glutathione S-transferase inhibitor, and FeTPPS (5,10,15,20-tetrakis(4-sulfonatophenyl)prophyrinato iron (III) chloride), a peroxynitrite decomposition catalyst. On the other hand, relatively low concentrations (10-100 microM) of nipradilol but not desnitro-nipradilol prevented neuronal cell death induced by 24 h application of 100 microM glutamate. Importantly, neuroprotective concentration (100 microM) of nipradilol suppressed glutamate-induced elevation...Continue Reading
References
Jun 1, 1992·Neuron·S Z LeiS A Lipton
Jul 15, 1991·Proceedings of the National Academy of Sciences of the United States of America·V L DawsonS H Snyder
Sep 1, 1990·Trends in Pharmacological Sciences·B Meldrum, J Garthwaite
Jun 1, 1989·Biochemical Pharmacology·R A YeatesM Leitold
Mar 1, 1986·Japanese Heart Journal·M FujiiM Nakamura
Sep 23, 1994·Science·Z HuangM A Moskowitz
Jan 1, 1994·Annual Review of Biochemistry·D S Bredt, S H Snyder
Dec 30, 1994·Cell·J B MannickJ S Stamler
Aug 1, 1995·Proceedings of the National Academy of Sciences of the United States of America·E BonfocoS A Lipton
Apr 1, 1995·The Journal of Clinical Investigation·A M GenaroL Boscá
Mar 3, 1994·The New England Journal of Medicine·S A Lipton, P A Rosenberg
Oct 19, 1993·Biochemical Pharmacology·P Seth, H L Fung
Jul 20, 1993·Biochemical Pharmacology·S R Kenkare, L Z Benet
Aug 12, 1993·Nature·S A LiptonJ S Stamler
Sep 1, 1996·Nature Medicine·P HantrayeM F Beal
Jun 1, 1996·Japanese Journal of Pharmacology·Y AniyaM Sakanashi
Nov 1, 1996·Pharmacology·T OkamuraN Toda
Jan 10, 1998·The Journal of Biological Chemistry·Y M KimT R Billiar
Nov 26, 1999·Neuron·W K KimS A Lipton
Aug 21, 2002·Current Eye Research·Toru NakazawaMakoto Tamai
Oct 3, 2002·European Journal of Pharmacology·Hiroshi TomitaMakoto Tamai
Mar 27, 2003·Investigative Ophthalmology & Visual Science·Kazue TakahataAkinori Akaike
Oct 3, 2003·European Journal of Pharmacology·Ryota TaguchiAkinori Akaike
Citations
Sep 22, 2012·Neurochemistry International·Yoshiki KoriyamaSatoru Kato
May 20, 2017·Neurochemical Research·Yoshiki Koriyama, Ayako Furukawa
Aug 13, 2008·Current Eye Research·Yasuko TatsumiMakoto Nakamura
Jul 17, 2007·American Journal of Physiology. Heart and Circulatory Physiology·Holly D Bauser-Heaton, H Glenn Bohlen
Feb 13, 2007·Pharmacological Research : the Official Journal of the Italian Pharmacological Society·Shyam S SharmaRavinder K Kaundal